Revive Therapeutics (RVV.C), a company that specializes in creating treatments and tests for diseases that don’t have many existing options available, has made a deal with a health research…
Psychedelics
A few weeks back, in what has become a seminal Equity.Guru piece about the quickly legalizing safe supply drug space, I tore into PharmaDrug (PHRX.C), which was lurching into…
Back at the dawn of Covid-19, a load of public companies started pumping out news releases that claimed they were going to be entering the medical space. In the…
We have some 29 companies on our watchlist, all in a variety of sectors, that we’re covering at any one time. Some are clients, some not, some are on…
I recently listened to a podcast episode of Search Engine with PJ Vogt, and I REALLY got into it. The episode was titled, “Why are drug dealers putting fentanyl…
Back in the day, I took great delight in pounding the absolute fucking shit out of a company called Namaste Technologies. I was not alone. There were many reasons…
Numinus Wellness (NUMI.T), a Canadian-based company focused on the development and delivery of innovative evidence-based psychedelic-assisted therapies, announced today that it had expanded its research capabilities into Arizona. The…
Cybin (CYBN.NEO), a Canadian-based biopharmaceutical company working to transform psychedelics into therapeutics, announced today that it had received approval from an independent ethics committee in the Netherlands to commence…
Psyence Group (PSYG.CN) is a life science biotechnology company with a focus on natural psychedelics. Psyence works with natural psilocybin products for the healing of psychological trauma and its…
On Tuesday September 27th 2022, psychedelics company MindMed (MMED.NE) announced the pricing of a public offering of common shares and warrants. An offering that the market saw as highly…